KBW Reaffirms 'Outperform' Rating for Globe Life with 22% Upside Potential

Key Facts

1Keefe, Bruyette & Woods reiterated an 'outperform' rating for Globe Life with a $168 price target.

2The price target indicates a potential 21.9% upside from current levels.

3Despite missing recent quarterly earnings and revenue estimates, the company showed strong margins and solid FY2026 EPS guidance.

Keefe, Bruyette & Woods (KBW) has maintained its 'Outperform' rating for Globe Life (NYSE: GL), setting a price target of $168 per share. This target suggests a significant potential upside of approximately 21.9% from the stock's current trading levels. Although Globe Life recently fell short of quarterly earnings and revenue estimates, analysts remain optimistic about its long-term financial trajectory. The firm highlighted the company's robust profit margins and solid earnings per share (EPS) guidance for the 2026 fiscal year as key drivers. KBW's assessment indicates that the underlying operational fundamentals and future growth prospects outweigh concerns regarding recent performance misses. This reaffirmation provides a positive signal to investors regarding the insurance provider's resilience and long-term value proposition.